Conférences  >  Médecine & Soins de Santé  >  Pharmacogénétique, Médecine personnalisée

ESMO - European Society for Medical Oncology

The ESMO Asia Congress is the annual event where global and Asian cancer professionals come together, to present and discuss the latest scientific and clinical advances across the entire field of oncology, of relevance at a global level, and for the Asia-Pacific region.

ESMO Registration Office;     Tél.: [+41 (0)91 973 19 13];     Email.: registration@esmo.org

Medical oncology, clinical oncology, surgical oncology, radiation oncology, oncology research, clinical practice guidelines, Pan-Asian Guidelines Adaptation

Cancérologie,    Médecine translationnelle, essais cliniques

IMPACT Conferences

We are glad to welcome all the participants to the "5th international conference on Pharmaceutics and Drug Delivery Research," (Virtual pharma 2022) scheduled for December 02-04, 2022. It mainly focuses on the theme “Innovative Approaches in Pharmaceutical Science and Drug Delivery systems". The conference will bring together academics, researchers, scientists, scholars, and professors, pharmacists, drug delivery specialists, nanotechnologists, clinicians, chemists, healthcare professionals, business representatives, and delegates from a wide range of disciplines to discuss the most recent findings and trends in pharmaceutics and drug delivery research. This three-day event includes keynote talks, oral presentations, poster sessions by young researchers and students, seminars, and networking opportunities.

Email.: pharmawebconference@gmail.com

• Advanced Drug Delivery Systems • Cellular Targeting and Intracellular Delivery • Pharmacogenomics • Drug Delivery Through BBB • Pharmacovigilance and Drug Safety • Pharmaceutical Research & Development • Novel Drug Delivery Systems, Biomarkers & Drug Targets • Nanotechnology in Pharmaceutics and Drug Delivery Systems • Pharmaceutical/Medicinal Chemistry • Pharmaceutical Microbiology & Biotechnology • Pharmacy Practice, Clinical and Hospital Pharmacy • Pharmaceutical Product Development and Manufacturing • Inhaled Drug Delivery • Research On Oncology And AIDS • Bio-Drugs, Bio-Molecules and Therapeutics • Biotherapy and Radiopharmaceuticals • Therapeutic Drug Carrier Systems • Drug Discovery and Screening • Anticancer drug delivery for Tumor Targeting • Preformulation Studies • Formulation Technologies • Vaccine Design and Drug Delivery Technology • Peptides and Protein Drug Delivery • Clinical And Medical Case Reports • Drug Discovery and Development • Pharmacognosy and Phytochemistry • Pharmacokinetics, Pharmacodynamics • Pharmacology & Toxicology • Nutraceuticals • Virtual Healthcare and Pharmaceuticals • Precision Medicine and Specialty Drugs • Cosmeceuticals • Biosimilars Market • Pharmaceutics Business and Market • Artificial Intelligence in Pharma • Regulatory Affairs and Quality Assurance

The 2023 GRS will focus on major areas pertaining to the design of RNA into rationally designed nanostructures. Sessions will follow the developmental pipeline from computational and structural design to use in applications as diagnostics, therapeutics, and materials. Challenges facing the field, including the cellular delivery of these formulations and the immune stimulation of nucleic acid-based nanostructures, will also be explored. The schedule will include talks on research findings as well as poster presentations to drive discussion on these topics and beyond.

Delivery, Design and Function of RNA Nanostructures

Génomique et bio-informatique,    Biologie moléculaire

The 2023 GRC on RNA Nanotechnology will promote scientific exchange and cross-disciplinary collaborations among scientists working in RNA chemistry, biology, biophysics, medicine, engineering and biotechnology. The nine sessions will feature presentations on nucleic acid structure and assembly, RNA modification, synthetic biology, nanostructures, biomaterials, extracellular vesicles, therapeutics, diagnostics, and imaging. Each session will also include short talks selected from abstracts submitted by poster presenters. Ample opportunities for extended discussions will be provided after each presentation and during breaks.

RNA Self-Assembly, Packaging, Imaging and Therapeutics

Génomique et bio-informatique,    Biologie moléculaire

SAE Media Group

Harnessing Alternative Rapid Microbial Methods for a Successful Contamination Control Strategy

Microbiology remains an essential tool for the detection of microorganisms present in biopharmaceutical and pharmaceutical batches. This conference will explore the most pressing topics in this thriving field, from the movement toward process automation and increased regulatory stringency, to the latest technologies in rapid microbiological testing methods and data integrity.

Tél.: [02078276162];     Email.: ssapal@smi-online.co.uk

Pharmaceutical, microbiology, contamination control, microbial, biofilms, sterility, quality assurance, mycoplasma, data integrity, microbiome, Endotoxin, Alternative Rapid Microbiological Methods

Pharmacologie et développement des médicaments,    Immunologie et Allergie

The 2023 Advancing Gene Therapy conference will be held in Hyatt Regency Boston, MA. The meeting will provide conference attendees updates on recent gene therapy innovations from vector designs to product launch. Drivers of these advances will be discussed including the rapid pace of change from biotechnology, pharmaceutical, manufacturing and CROs with preclinical, non-clinical and trial expertise. In addition, the summit covers emerging and related fields including Gene Editing & CRISPR, Cell Therapies, Gene Therapy for Cancer, Immunotherapy, Rare diseases, Blood Disorders, Neurological Disorders, Toxicology Studies, advances in manufacturing, regulatory and medical affairs, Commercialization Strategies, Business Models and Market Access.

Cellules souches,    Biotechnologie

European Molecular Biology Organization – EMBO

The discovery of myriad noncoding RNAs (ncRNAs) over the past decade has revealed a universe of new and exciting therapeutic opportunities. Many thousands of microRNAs, piRNAs, circular RNAs, long noncoding RNAs, and others are expressed across healthy and diseased human tissues and play key functional roles in pathogenic states and processes. Their regulatory roles, cell-type-specificity, and vast numbers confer on ncRNAs unique advantages as therapeutic targets. Rapid advances in clinical transcriptomics, oligonucleotide therapeutics, and RNA-directed small molecules, open the possibility for rapid, economical, and personalised ncRNA-directed therapies. Reaching this goal will require overcoming key challenges, including low evolutionary conservation in model species, poorly-characterised molecular mechanisms, finding hits amongst the vast ncRNA transcriptome, and effectively drugging targets in vivo. This EMBO Workshop will bring together colleagues from both academic and commercial worlds to discuss their latest progress in these issues. Sessions will cover the full span from basic disease biology to therapeutic development. Confirmed speakers represent leaders from around the globe, and numerous slots have been set aside for oral presentations selected from submitted abstracts.

Cancérologie,    Médecine translationnelle, essais cliniques